Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ALGS

Aligos Therapeutics (ALGS)

Aligos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALGS
DateTimeSourceHeadlineSymbolCompany
09/19/20248:00AMGlobeNewswire Inc.Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASHNASDAQ:ALGSAligos Therapeutics Inc
09/18/20245:00PMGlobeNewswire Inc.Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024NASDAQ:ALGSAligos Therapeutics Inc
09/13/20248:00AMGlobeNewswire Inc.Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALGSAligos Therapeutics Inc
09/06/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALGSAligos Therapeutics Inc
09/05/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
08/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
08/15/20249:00AMGlobeNewswire Inc.Aligos Therapeutics Announces Reverse Stock SplitNASDAQ:ALGSAligos Therapeutics Inc
08/09/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALGSAligos Therapeutics Inc
08/09/20244:08PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALGSAligos Therapeutics Inc
08/08/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
08/08/20244:05PMGlobeNewswire Inc.Aligos Therapeutics Strengthens Board with Two New Independent DirectorsNASDAQ:ALGSAligos Therapeutics Inc
08/06/20244:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALGSAligos Therapeutics Inc
08/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
08/06/20244:05PMGlobeNewswire Inc.Aligos Therapeutics Reports Recent Business Progress andĀ Second Quarter 2024 Financial ResultsNASDAQ:ALGSAligos Therapeutics Inc
07/30/20244:05PMGlobeNewswire Inc.Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024NASDAQ:ALGSAligos Therapeutics Inc
07/22/20249:00AMGlobeNewswire Inc.Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.NASDAQ:ALGSAligos Therapeutics Inc
07/10/20248:00AMGlobeNewswire Inc.Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHBNASDAQ:ALGSAligos Therapeutics Inc
06/05/20242:30AMGlobeNewswire Inc.Aligos Therapeutics Presents Positive Data at the EASL Congress 2024NASDAQ:ALGSAligos Therapeutics Inc
05/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
05/22/20244:05PMGlobeNewswire Inc.Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024NASDAQ:ALGSAligos Therapeutics Inc
05/22/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
05/21/20248:00AMGlobeNewswire Inc.Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASHNASDAQ:ALGSAligos Therapeutics Inc
05/15/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
05/07/20244:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALGSAligos Therapeutics Inc
05/07/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALGSAligos Therapeutics Inc
05/07/20244:05PMGlobeNewswire Inc.Aligos Therapeutics Reports Recent Business Progress andĀ First Quarter 2024 Financial ResultsNASDAQ:ALGSAligos Therapeutics Inc
04/30/20244:05PMGlobeNewswire Inc.Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024NASDAQ:ALGSAligos Therapeutics Inc
04/25/20244:05PMGlobeNewswire Inc.Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 StudyNASDAQ:ALGSAligos Therapeutics Inc
04/25/20248:00AMGlobeNewswire Inc.Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MDNASDAQ:ALGSAligos Therapeutics Inc
04/09/20248:00AMGlobeNewswire Inc.Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024NASDAQ:ALGSAligos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ALGS